BalchemvsCorteva

BCPC and CTVA stock compared: price, dividend, valuation and results, from SEC filings.

Over the last year, with dividends, BCPC moved +11.3% and CTVA -8.0%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    BCPC$5.6B

    CTVA–

  • Revenue, 12 months

    BCPC$1.1B

    CTVA$17.7B

    CTVA is 16 times BCPC

  • Net income, 12 months

    BCPC$171M

    CTVA$759M

    CTVA is 4.4 times BCPC

  • Operating margin

    BCPC20.7%

    CTVA–

  • ROIC

    BCPC13.8%

    CTVA3.0%

    10.8 points apart

  • P/E

    BCPC32.5

    CTVA–

  • Dividend yield

    BCPC0.0%

    CTVA0.0%

    About the same

  • 5-year return

    BCPC+8.4%

    CTVA+30.7%

    22.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

BCPC+8.4%

CTVA+30.7%

10015020020222023202420252026
Returns by period
PeriodBCPCWith dividendsCTVAWith dividends
1 year since November 14, 2025+11.3%Price +10.6%-8.0%Price -8.9%
3 years since November 16, 2023+42.2%+12.4% a yearPrice +39.8%+32.1%+9.7% a yearPrice +27.9%
5 years since November 15, 2021+8.4%+1.6% a yearPrice +5.6%+30.7%+5.5% a yearPrice +24.2%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

BCPCBalchemCTVACorteva

Valuation

BCPCCTVA
Valuation
Price$173.40$9.04
Market value$5.6B–
Enterprise value (EV)$5.6B–
P/E32.5–
P/E, 5-year median41.541.9
P/B4.2–
EV/EBIT24.5–
Free cash flow yield3.2%–

Results and growth

BCPCCTVA
Results and growth
Revenue, 12 months$1.1B$17.7B
Net income, 12 months$171M$759M
Free cash flow, 12 months$178M-$149M
Earnings per share, 12 months$5.31$1.14
Revenue growth, year on year8.8%2.9%
Revenue growth a year, past+8.1%over 5 years+4.1%over 5 years
EPS growth a year, past+12.8%over 5 years+12.0%over 5 years

Margins and returns on capital

BCPCCTVA
Margins and returns on capital
Gross margin36.5%49.7%
Operating margin20.7%–
Net margin15.4%4.3%
ROIC13.8%3.0%
ROE13.2%3.1%

Balance sheet

BCPCCTVA
Balance sheet
Cash$66M$3.9B
Total debt$142M$7.4B
Net debt / EBITDA0.21.4
Interest cover–6.7×

Dividends and buybacks

BCPCCTVA
Dividends and buybacks
Dividend yield––
Dividend per share, 12 months–$0.72
Dividend growth a year, past+11.1%over 5 years+6.1%over 5 years
Buyback yield1.9%–
Shareholder yield1.9%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: BCPC or CTVA

Didn't find what you were looking for?

Ask us
How did BCPC and CTVA stock do over the last 5 years?

Since November 15, 2021, BCPC's price moved +5.6% and CTVA's +24.2%. With dividends: BCPC +8.4% (+1.6% a year), CTVA +30.7% (+5.5% a year). Past returns do not predict future ones.

Which pays the higher dividend, BCPC or CTVA?

Neither paid a dividend over the last twelve months: Balchem and Corteva return money to shareholders, if they do, in other ways, such as buybacks.

Which has the higher profit margins, Balchem or Corteva?

Over the last twelve months, the net margin was 15.4% for Balchem and 4.3% for Corteva, and the operating margin 20.7% and –. Revenue was $1.1B and $17.7B.

Which is the better investment, Balchem or Corteva?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.